Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Rodríguez, Ana Eugenia ^a   Hernández, Jose Ángel ^b   Benito, Rocío ^a   Gutiérrez, Norma C ^c   García, Juan Luis ^d   Hernández Sánchez, María ^a   Risueño, Alberto ^e,f   Sarasquete, M Eugenia ^c   Fermiñán, Encarna ^a   Fisac, Rosa ^g   de Coca, Alfonso García ^h   Martín Núñez, Guillermo ⁱ   de las Heras, Natalia ^j   Recio, Isabel ^k   Gutiérrez, Oliver ^l   de Las Rivas, Javier ^e   González, Marcos ^a,c   Hernández Rivas, Jesús M ^a,c  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d Instituto de Estudios de Ciencias de la Salud de Castilla y León IECSCYL HUSAL   (Spain)

^e CSIC   (Spain)

^f Celgene Institute for Translational Research Europe CITRE   (Spain)

^g HOSPITAL GENERAL DE SEGOVIA   (Spain)

^h HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

ⁱ HOSPITAL VIRGEN DEL PUERTO   (Spain)

^j Hospital Virgen Blanca   (Spain)

^k HOSPITAL NUESTRA SEÑORA DE SONSOLES   (Spain)

^l HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 155; MICRORNA 15A; MICRORNA 223; MICRORNA 29A;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER STAGING; CELL ISOLATION; CELL PROLIFERATION; CHROMOSOME 13Q; CHROMOSOME 13Q14; CHROMOSOME LOSS; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 17; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MICRORNAS; MIDDLE AGED; MUTATION; SIGNAL TRANSDUCTION;

EID: 84869003199     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048485     Document Type: Article

References (46)

1. Chiorazzi N, Rai KR, Ferrarini M, (2005) Chronic lymphocytic leukemia. N Engl J Med 352: 804-815.
2. Keating MJ, (1999) Chronic lymphocytic leukemia. Semin Oncol 26: 107-114.
3. Dighiero G, (2003) Unsolved issues in CLL biology and management. Leukemia 17: 2385-2391.
4. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK, (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94: 1848-1854.
5. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, et al. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343: 1910-1916.
6. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94: 1840-1847.
7. Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, et al. (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100: 1410-1416.
8. Lin K, Sherrington PD, Dennis M, Matrai Z, Cawley JC, et al. (2002) Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Blood 100: 1404-1409.
9. Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, et al. (2002) Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 100: 1177-1184.
10. Mehes G, (2005) Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia. Pathol Oncol Res 11: 205-210.
11. Hernandez JA, Rodriguez AE, Gonzalez M, Benito R, Fontanillo C, et al. (2009) A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia. Haematologica 94: 364-371.
12. Van Dyke DL, Shanafelt TD, Call TG, Zent CS, Smoley SA, et al. (2010) A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia. Br J Haematol 148: 544-550.
13. Dal BM, Rossi FM, Rossi D, Deambrogi C, Bertoni F, et al. (2011) 13q14 Deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia. Genes Chromosomes Cancer 50: 633-643.
14. Catovsky D, Richards S, Matutes E, Oscier D, Dyer MJ, et al. (2007) Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet 370: 230-239.
15. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, et al. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17: 3835-3849.
16. Binet JL, Caligaris-Cappio F, Catovsky D, Cheson B, Davis T, et al. (2006) Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. Blood 107: 859-861.
17. Sanchez ML, Almeida J, Gonzalez D, Gonzalez M, Garcia-Marcos MA, et al. (2003) Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone. Blood 102: 2994-3002.
18. Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stilgenbauer S, et al. (2007) ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 21: 1-3.
19. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
20. Risueno A, Fontanillo C, Dinger ME, de las RJ (2010) GATExplorer: genomic and transcriptomic explorer; mapping expression probes to gene loci, transcripts, exons and ncRNAs. BMC Bioinformatics 11: 221-.
21. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
22. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I, (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284.
23. Goeman JJ, van de Geer SA, de KF, van Houwelingen HC, (2004) A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 20: 93-99.
24. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80-.
25. Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A (2007) GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol 8: R3-.
26. Chiorazzi N, (2007) Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells. Best Pract Res Clin Haematol 20: 399-413.
27. Guarini A, Chiaretti S, Tavolaro S, Maggio R, Peragine N, et al. (2008) BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells. Blood 112: 782-792.
28. Rodriguez A, Villuendas R, Yanez L, Gomez ME, Diaz R, et al. (2007) Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation. Leukemia 21: 1984-1991.
29. Buchner M, Fuchs S, Prinz G, Pfeifer D, Bartholome K, et al. (2009) Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia. Cancer Res 69: 5424-5432.
30. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, et al. (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463: 88-92.
31. Su TT, Guo B, Kawakami Y, Sommer K, Chae K, et al. (2002) PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol 3: 780-786.
32. Bernal A, Pastore RD, Asgary Z, Keller SA, Cesarman E, et al. (2001) Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood 98: 3050-3057.
33. Gutierrez A Jr, Tschumper RC, Wu X, Shanafelt TD, Eckel-Passow J, et al. (2010) LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood 116: 2975-2983.
34. Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M, et al. (2004) Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 101: 3118-3123.
35. Reya T, O'Riordan M, Okamura R, Devaney E, Willert K, et al. (2000) Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13: 15-24.
36. Longo PG, Laurenti L, Gobessi S, Sica S, Leone G, et al. (2008) The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood 111: 846-855.
37. Calin GA, Ferracin M, Cimmino A, Di LG, Shimizu M, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801.
38. Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, et al. (2009) Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 114: 3872-3879.
39. Stamatopoulos B, Meuleman N, Haibe-Kains B, Saussoy P, Van Den NE, et al. (2009) microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 113: 5237-5245.
40. Li S, Moffett HF, Lu J, Werner L, Zhang H, et al. (2011) MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. PLoS One 6: e16956-.
41. Yin Q, Wang X, McBride J, Fewell C, Flemington E, (2008) B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J Biol Chem 283: 2654-2662.
42. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102: 13944-13949.
43. Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, et al. (2006) Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66: 11590-11593.
44. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, et al. (2008) MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 105: 5166-5171.
45. Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, et al. (2011) Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475: 101-105.
46. Quesada V, Conde L, Villamor N, Ordonez GR, Jares P, et al. (2011) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44: 47-52.